Zvi Laron1, Shira Ginsberg, Muriel Webb. 1. Endocrinology and Diabetes Research Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel. laronz@clalit.org.il
Abstract
BACKGROUND: There is little information on the relationship between growth hormone/insulin-like growth factor-I (GH/IGF-I) deficiency or IGF-I treatment on nonalcoholic fatty liver disease (NAFLD) a disorder linked to obesity and insulin resistance. OBJECTIVE: To find out whether the markedly obese patients with Laron syndrome (LS) and GH gene deletion have fatty livers. SUBJECTS: We studied 11 untreated adult patients with LS (5M, 6F), five girls with LS treated by IGF-I and five adult patients with GH gene deletion (3M, 3F), four previously treated by hGH in childhood. METHODS: Fatty liver was quantitatively evaluated by ultrasonography using a phase array US system (HITACHI 6500, Japan). Body adiposity was determined by DEXA, and insulin resistance was estimated by HOMA-IR using the fasting serum glucose and insulin values. RESULTS: Six out of 11 adult patients with LS, two out of the five IGF-I treated girls with LS and three out of five adult hGH gene deletion patients were found to have NAFLD (nonalcoholic fatty liver disease). CONCLUSION: NAFLD is a frequent complication in untreated and treated congenital IGF-I deficiency. No correlation between NAFLD and age, sex, degree of obesity, blood lipids, or degree of insulin resistance was observed.
BACKGROUND: There is little information on the relationship between growth hormone/insulin-like growth factor-I (GH/IGF-I) deficiency or IGF-I treatment on nonalcoholic fatty liver disease (NAFLD) a disorder linked to obesity and insulin resistance. OBJECTIVE: To find out whether the markedly obesepatients with Laron syndrome (LS) and GH gene deletion have fatty livers. SUBJECTS: We studied 11 untreated adult patients with LS (5M, 6F), five girls with LS treated by IGF-I and five adult patients with GH gene deletion (3M, 3F), four previously treated by hGH in childhood. METHODS: Fatty liver was quantitatively evaluated by ultrasonography using a phase array US system (HITACHI 6500, Japan). Body adiposity was determined by DEXA, and insulin resistance was estimated by HOMA-IR using the fasting serum glucose and insulin values. RESULTS: Six out of 11 adult patients with LS, two out of the five IGF-I treated girls with LS and three out of five adult hGH gene deletion patients were found to have NAFLD (nonalcoholic fatty liver disease). CONCLUSION: NAFLD is a frequent complication in untreated and treated congenital IGF-I deficiency. No correlation between NAFLD and age, sex, degree of obesity, blood lipids, or degree of insulin resistance was observed.
Authors: David L Carbone; Damian G Zuloaga; Ryoko Hiroi; Chad D Foradori; Marie E Legare; Robert J Handa Journal: Endocrinology Date: 2011-11-08 Impact factor: 4.736
Authors: Darlene E Berryman; Edward O List; Amanda J Palmer; Min-Yu Chung; Jacob Wright-Piekarski; Ellen Lubbers; Patrick O'Connor; Shigeru Okada; John J Kopchick Journal: J Gerontol A Biol Sci Med Sci Date: 2009-11-09 Impact factor: 6.053
Authors: Edward O List; Lucila Sackmann-Sala; Darlene E Berryman; Kevin Funk; Bruce Kelder; Elahu S Gosney; Shigeru Okada; Juan Ding; Diana Cruz-Topete; John J Kopchick Journal: Endocr Rev Date: 2010-12-01 Impact factor: 19.871
Authors: Edward O List; Darlene E Berryman; Mathew Buchman; Elizabeth A Jensen; Kevin Funk; Silvana Duran-Ortiz; Yanrong Qian; Jonathan A Young; Julie Slyby; Savannah McKenna; John J Kopchick Journal: Endocrinology Date: 2019-07-01 Impact factor: 4.736
Authors: Jose Cordoba-Chacon; Neena Majumdar; Edward O List; Alberto Diaz-Ruiz; Stuart J Frank; Anna Manzano; Ramon Bartrons; Michelle Puchowicz; John J Kopchick; Rhonda D Kineman Journal: Diabetes Date: 2015-05-26 Impact factor: 9.461
Authors: Kristina M Mueller; Madeleine Themanns; Katrin Friedbichler; Jan-Wilhelm Kornfeld; Harald Esterbauer; Jan P Tuckermann; Richard Moriggl Journal: Mol Cell Endocrinol Date: 2012-04-30 Impact factor: 4.102